Back to Journals » OncoTargets and Therapy » Volume 12

Profile of alectinib for the treatment of ALK-positive non-small cell lung cancer (NSCLC): patient selection and perspectives

Total article views   HTML views PDF downloads Totals
10,250 Dovepress* 8,033+ 1,270 9,303
PubMed Central* 2,217 637 2,854
Totals 10,250 1,907 12,157
*Since 13 June 2019
Total mentioned Facebook Delicious Reddit Twitter Others
7 0 0 1 2 4

View citations on PubMed Central and Google Scholar